100 Aetas in Angeles City inoculated vs COVID-19 | Inquirer

100 Aetas in Angeles City inoculated vs COVID-19

/ 12:02 PM November 01, 2021

An Aeta woman gets her first dose of the vaccine against COVID-19 in the upland village of Sapangbato

An Aeta woman gets her first dose of the vaccine against COVID-19 in the upland village of Sapangbato. (Photo from the Angeles City government)

ANGELES CITY––Some 100 Aetas in Sapangbato village in this city have been vaccinated against COVID-19, the city government said Sunday, Oct. 31.

In a statement, it said the inoculation of the Aetas was in line with the city’s celebration of Indigenous People’s Month in October.

Article continues after this advertisement

Mayor Carmelo Lazatin Jr. said the Aetas in remote areas also needed to be protected against the disease.

FEATURED STORIES

He said 107 Aetas received their first dose of the vaccine on Oct. 29, while 45 others earlier vaccinated were given their second dose on the same day.

Lazatin said 168 Aetas were vaccinated against COVID-19 via the city’s “Ronda Bakuna” mobile bus clinic last September.

Article continues after this advertisement

The mayor said they distributed P2,000 in cash, food packages, and vegetable seeds to some 313 Aeta families in Sapangbato.

lzb
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this

TAGS: Aetas, Angeles City, COVID-19, Regions, Sapangbato, Vaccination

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.